During the past decade, Belmont Center for Comprehensive Treatment conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 7 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Belmont Center for Comprehensive Treatment" #1 sponsor was "Pfizer" with 3 trials, followed by "Cephalon" with 2 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials sponsored, "Shire" with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Belmont Center for Comprehensive Treatment" #1 collaborator was "Otsuka America Pharmaceutical" with 2 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Belmont Center for Comprehensive Treatment" are "Schizophrenia" (4 trials), "Depression" (2 trials), "Major Depressive Disorder" (2 trials), "Smoking Cessation" (2 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Belmont Center for Comprehensive Treatment" in a lesser frequency.

Most popular intervention types in "Belmont Center for Comprehensive Treatment" are "Drug" (13 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "placebo" (3 trials), "Nicotine Replacement Therapy Patch" (2 trials), "bupropion hydrochloride" (2 trials) and "varenicline tartrate" (2 trials). Other intervention names were less common.

The vast majority of trials in "Belmont Center for Comprehensive Treatment" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Belmont Center for Comprehensive Treatment". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Belmont Center for Comprehensive Treatment, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Belmont Center for Comprehensive Treatment, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 0 trials that are defined as “Not Applicable".